Best Medical Stocks To Own Right Now

WellCare (NYSE: WCG) and Trupanion (NASDAQ:TRUP) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations and profitability.

Valuation and Earnings

Get WellCare alerts:

This table compares WellCare and Trupanion’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
WellCare $17.01 billion 0.58 $373.70 million $8.52 25.83
Trupanion $242.67 million 4.07 -$1.50 million ($0.07) -452.14

WellCare has higher revenue and earnings than Trupanion. Trupanion is trading at a lower price-to-earnings ratio than WellCare, indicating that it is currently the more affordable of the two stocks.

Best Medical Stocks To Own Right Now: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peer Central Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Freshpet (FRPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Freshpet Inc  (NASDAQ:FRPT)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Medical Stocks To Own Right Now: Coffee Holding Co., Inc.(JVA)

Advisors’ Opinion:

  • [By Max Byerly]

    Coffee (NASDAQ:JVA) posted its earnings results on Friday. The company reported $0.00 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.07 by ($0.07), MarketWatch Earnings reports. Coffee had a return on equity of 3.99% and a net margin of 1.23%. The firm had revenue of $23.44 million during the quarter.

Best Medical Stocks To Own Right Now: Athene Holding Ltd. (ATH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Athene Holding Ltd (NYSE:ATH) insider Grant Kvalheim sold 4,068 shares of the company’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $50.00, for a total transaction of $203,400.00. Following the completion of the sale, the insider now owns 1,631,434 shares of the company’s stock, valued at $81,571,700. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

  • [By Max Byerly]

    Athabasca Oil (TSE:ATH) had its price objective hoisted by Raymond James from C$2.00 to C$2.50 in a research report released on Tuesday morning.

    Other research analysts also recently issued research reports about the company. GMP Securities increased their price objective on Athabasca Oil from C$1.65 to C$2.25 in a report on Tuesday, May 15th. TD Securities upped their target price on Athabasca Oil from C$1.75 to C$2.25 and gave the company a buy rating in a research report on Thursday, May 10th. BMO Capital Markets upped their target price on Athabasca Oil from C$1.60 to C$2.25 and gave the company a market perform rating in a research report on Thursday, May 10th. Finally, Royal Bank of Canada upped their target price on Athabasca Oil from C$2.00 to C$2.50 and gave the company an outperform rating in a research report on Thursday, May 10th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of C$2.23.

  • [By Max Byerly]

    Athabasca Oil (TSE:ATH) had its price objective upped by Royal Bank of Canada from C$2.00 to C$2.50 in a report released on Thursday. The firm presently has an “outperform” rating on the oil and gas exploration company’s stock. Royal Bank of Canada’s price objective points to a potential upside of 30.89% from the company’s current price.

  • [By Stephan Byrd]

    Athene Holding Ltd (NYSE:ATH) insider Grant Kvalheim sold 2,505 shares of the company’s stock in a transaction on Thursday, August 23rd. The shares were sold at an average price of $50.01, for a total value of $125,275.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Best Medical Stocks To Own Right Now: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.Stonemor Partners LP (STON) – 6,650,613 shares, 68.21% of the total portfolio. Shares added by 8.91%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 21.11% of the total portfolio. Stage Stores Inc (SSI) – 1,750,000 shares, 6.3% of the total portfolio. Shares added by 75.00%Five Star Senior Living Inc (FVE) – 2,039,878 shares, 4.38% of the total portfolio. Added

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/guru/axar+capital+management+l.p./current-portfolio/portfolio

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.SPDR S&P 500 (SPY) – 1,220,000 shares, 91.31% of the total portfolio. Stonemor Partners LP (STON) – 7,384,970 shares, 4.64% of the total portfolio. Shares added by 7.35%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 2.26% of the total portfolio. Independence Contract Drilling Inc (ICD) – 969,662 shares, 0.91% of the total portfolio. New PositionStage Stores Inc (SSI) – 3,700,000 shares, 0.82% of the total portfolio. Shares added by 6

  • [By Lisa Levin] Companies Reporting Before The Bell
    Best Buy Co., Inc. (NYSE: BBY) is projected to report quarterly earnings at $0.74 per share on revenue of $8.73 billion.
    McKesson Corporation (NYSE: MCK) is expected to report quarterly earnings at $3.56 per share on revenue of $51.25 billion.
    Medtronic plc (NYSE: MDT) is estimated to report quarterly earnings at $1.39 per share on revenue of $8.00 billion.
    Hormel Foods Corporation (NYSE: HRL) is projected to report quarterly earnings at $0.45 per share on revenue of $2.39 billion.
    Brady Corporation (NYSE: BRC) is expected to report quarterly earnings at $0.49 per share on revenue of $291.47 million.
    Sanderson Farms, Inc. (NASDAQ: SAFM) is projected to report quarterly earnings at $2.2 per share on revenue of $841.75 million.
    The Toronto-Dominion Bank (NYSE: TD) is estimated to report quarterly earnings at $1.16 per share on revenue of $6.86 billion.
    Royal Bank of Canada (NYSE: RY) is expected to report quarterly earnings at $1.61 per share on revenue of $8.05 billion.
    58.com Inc. (NYSE: WUBA) is projected to report quarterly earnings at $0.21 per share on revenue of $372.49 million.
    Luxoft Holding, Inc. (NYSE: LXFT) is estimated to report quarterly earnings at $0.59 per share on revenue of $228.53 million.
    The Toro Company (NYSE: TTC) is expected to report quarterly earnings at $1.21 per share on revenue of $916.73 million.
    StealthGas Inc. (NASDAQ: GASS) is projected to report quarterly earnings at $0.06 per share on revenue of $37.75 million.
    Stage Stores, Inc. (NYSE: SSI) is estimated to report earnings for its first quarter.
    Thermon Group Holdings, Inc. (NYSE: THR) is projected to report quarterly earnings at $0.2 per share on revenue of $96.24 million.
    Tuniu Corporation (NASDAQ: TOUR) is estimated to report quarterly loss at $0.03 per share on revenue of $76.72 million.

     

  • [By Lisa Levin] Gainers
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) rose 32 percent to $2.89 in pre-market trading after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) rose 17.7 percent to $3.03 in pre-market trading after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) shares rose 12.7 percent to $3.55 in pre-market trading after the company announced the FDA acceptance of NDA for DSUVIA.
    Williams-Sonoma, Inc. (NYSE: WSM) shares rose 11.7 percent to $54.95 in pre-market trading. after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    Bilibili Inc. (NASDAQ: BILI) shares rose 9.3 percent to $13.59 in pre-market trading after announcing Q1 results.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 8.1 percent to $3.46 in pre-market trading after reporting strong Q1 earnings.
    Universal Corporation (NYSE: UVV) rose 8.1 percent to $52.35 in pre-market trading after reporting fiscal Q4 results.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) rose 8.1 percent to $5.65 in pre-market trading after gaining 6.30 percent on Wednesday.
    CEL-SCI Corporation (NYSE: CVM) rose 6.1 percent to $3.30 in pre-market trading after climbing 9.51 percent on Wednesday.
    TransEnterix, Inc. (NYSE: TRXC) rose 6 percent to $3.10 in pre-market trading after reporting a loan deal for $40 million in term loans with Hercules Capital.
    Stage Stores, Inc. (NYSE: SSI) rose 5.6 percent to $3.40 in pre-market trading following Q1 results.
    Koss Corporation (NASDAQ: KOSS) shares rose 5.2 percent to $2.42 in the pre-market trading session after falling 2.54 percent on Wednesday.

     

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.iShares Russell 2000 (IWM) – 1,060,000 shares, 73.71% of the total portfolio. Stonemor Partners LP (STON) – 6,650,613 shares, 17.03% of the total portfolio. Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 5.58% of the total portfolio. Stage Stores Inc (SSI) – 2,115,200 shares, 2.16% of the total portfolio. Shares added by 20.87%Five Star Senior Living Inc (FVE) – 2,073,398 shares, 1.32% of the total portfolio. Shares added by

Best Medical Stocks To Own Right Now: MyoKardia, Inc.(MYOK)

Advisors’ Opinion:

  • [By Logan Wallace]

    Myokardia Inc (NASDAQ:MYOK) insider June Lee sold 5,000 shares of the stock in a transaction dated Friday, September 21st. The shares were sold at an average price of $63.13, for a total value of $315,650.00. Following the completion of the transaction, the insider now directly owns 5,426 shares of the company’s stock, valued at approximately $342,543.38. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Logan Wallace]

    Shares of Myokardia Inc (NASDAQ:MYOK) have been assigned an average recommendation of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $69.50.

  • [By Max Byerly]

    Equities researchers at Cantor Fitzgerald assumed coverage on shares of Myokardia (NASDAQ:MYOK) in a note issued to investors on Monday, The Fly reports. The brokerage set an “overweight” rating on the biotechnology company’s stock.

Best Medical Stocks To Own Right Now: Acacia Research Corporation(ACTG)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Acacia Research alerts:

    Acacia Research to Release Second Quarter Financial Results (finance.yahoo.com) Acacia Research Announces Changes to Board of Directors (finance.yahoo.com) Acacia Research: Miso Robotics’ Kitchen Assistant, Flippy, May Be Worth Flipping Over (seekingalpha.com) Acacia Research (ACTG) Scheduled to Post Quarterly Earnings on Friday (americanbankingnews.com)

    A number of research analysts have weighed in on ACTG shares. Zacks Investment Research upgraded shares of Acacia Research from a “sell” rating to a “hold” rating in a research report on Tuesday, July 3rd. ValuEngine downgraded shares of Acacia Research from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd.

  • [By Stephan Byrd]

    Acacia Research Corp (NASDAQ:ACTG) reached a new 52-week low during trading on Wednesday . The company traded as low as $3.00 and last traded at $3.06, with a volume of 4160 shares. The stock had previously closed at $3.15.

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

  • [By Logan Wallace]

    These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Acacia Research alerts:

    Insider Selling: Acacia Research Corp (ACTG) President Sells 46,143 Shares of Stock (americanbankingnews.com) Insider Selling: Acacia Research Corp (ACTG) President Sells 66,115 Shares of Stock (americanbankingnews.com) Insider Buying: Acacia Research Corp (ACTG) Insider Acquires 10,000 Shares of Stock (americanbankingnews.com) It may surprise you: OncoSec Medical Incorporated (NASDAQ:ONCS), Mizuho Financial Group, Inc. (NYSE:MFG … (thestreetpoint.com)

    Shares of NASDAQ ACTG traded down $0.05 during midday trading on Tuesday, hitting $3.45. 1,710 shares of the company traded hands, compared to its average volume of 147,059. Acacia Research has a 12-month low of $3.25 and a 12-month high of $5.50. The stock has a market capitalization of $173.23 million, a P/E ratio of 1.16 and a beta of 0.94.

  • [By Shane Hupp]

    Media coverage about Acacia Research (NASDAQ:ACTG) has trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative media coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Acacia Research earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned media coverage about the business services provider an impact score of 46.8999050024634 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Leave a Reply

Your email address will not be published. Required fields are marked *